Financial Times – In a story about the IEX filing an Amicus Breif to the SEC regarding market data fees charged by NYSE and Nasdaq, Tyler Gellasch, Executive Director of Healthy Markets is quoted saying that “the filing from IEX introduces some potentially powerful facts”. Mr. Gellasch further states “it’s easy for the SEC to say NYSE and Nasdaq haven’t ligitimised the price of market data, but it’s another to have hard facts to highlight this – IEX is uniquely placed to do that”. (full story).
Reader Interactions